These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6749638)

  • 1. Changes in proteolytic activities of human leukemic promyelocytes (HL-60 cells) during maturation.
    Kidron M; Friedman DB; Mayer M; Klemes Y; Fibach E
    Hoppe Seylers Z Physiol Chem; 1982 Aug; 363(8):865-9. PubMed ID: 6749638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in acid proteolytic activity during differentiation of murine erythroleukemic cells.
    Kidron M; Fibach E; Klemes Y; Mayer M
    Cell Differ; 1981 Dec; 10(6):309-15. PubMed ID: 7032707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of differentiation in human myeloid leukemic cells by proteolytic enzymes.
    Fibach E; Treves A; Kidron M; Mayer M
    J Cell Physiol; 1985 May; 123(2):228-34. PubMed ID: 3884635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new protease in hog thyroid lysosomes. I. The presence of a leupeptin-sensitive protease in the soluble fraction of thyroid lysosomes.
    Nakagawa H; Endo Y; Ohtaki S
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):383-9. PubMed ID: 7027711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of cartilage proteoglycans by myeloid leukemia cells.
    Luikart SD
    Exp Hematol; 1988 Feb; 16(2):102-5. PubMed ID: 3276541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.
    Collins SJ; Ruscetti FW; Gallagher RE; Gallo RC
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2458-62. PubMed ID: 276884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation.
    Newburger PE; Chovaniec ME; Greenberger JS; Cohen HJ
    J Cell Biol; 1979 Aug; 82(2):315-22. PubMed ID: 225336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of human myeloid leukemia cells into normal granulocytes and macrophages: activity and intracellular distribution of catalase.
    Kos Z; Pavelić L; Pekić B; Pavelić K
    Oncology; 1987; 44(4):245-7. PubMed ID: 3475645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
    Schwartz EL; Sartorelli AC
    Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of differentiation of fresh myelogenous leukemic cells by compounds that induce a human promyelocytic leukemic line (HL-60) to differentiate.
    Koeffler HP; Yelton L; Prokocimer M; Hirji K
    Leuk Res; 1985; 9(1):73-81. PubMed ID: 3857407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and properties of cytidine deaminase from normal and leukemic granulocytes.
    Chabner BA; Johns DG; Coleman CN; Drake JC; Evans WH
    J Clin Invest; 1974 Mar; 53(3):922-31. PubMed ID: 4521417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New facts and speculations on human myeloid leukemias.
    Breitman TR; Gallo RC
    Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the maturation of human leukemic promyelocytes (HL-60) to granulocytes or macrophages.
    Fibach E; Peled T; Treves A; Kornberg A; Rachmilewitz EA
    Leuk Res; 1982; 6(6):781-90. PubMed ID: 6961271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of HL-60 cells with dimethyl sulphoxide inhibits the formation of beta-N-acetylhexosaminidase S.
    Emiliani C; Falzetti F; Orlacchio A; Stirling JL
    Biochem J; 1990 Nov; 272(1):211-5. PubMed ID: 2148259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical activities of lysosomal acid hydrolases in leukemic cells.
    Tanaka T; Kobayashi M; Saito O; Kamada N; Kuramoto A; Usui T
    Clin Chim Acta; 1981 Dec; 117(2):121-31. PubMed ID: 6946881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid changes in bidirectional K+ fluxes preceding DMSO-induced granulocytic differentiation of HL-60 human leukemic cells.
    Gargus JJ; Adelberg EA; Slayman CW
    J Cell Physiol; 1984 Jul; 120(1):83-90. PubMed ID: 6588052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models.
    Sohar I; Sleat DE; Jadot M; Lobel P
    J Neurochem; 1999 Aug; 73(2):700-11. PubMed ID: 10428067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of a vimentin-specific protease in mouse myeloid leukemia cells. Regulation during differentiation and identity with cathepsin G.
    Nakamura N; Tsuru A; Hirayoshi K; Nagata K
    Eur J Biochem; 1992 May; 205(3):947-54. PubMed ID: 1577012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.